// App-Quantinova.ai

PB0960 : Safety and Efficacy of FVIII Replacement with Turoctocog Alfa in the UK

Researchers

Presenter

  • B. Palmer

Principal Investigators

  • H. Xiang

  • P. Collins

  • G. Dolan

  • J. Hanley

  • S. Shapiro

  • C. Hay

Medical Centers

  • UK National Haemophilia Database, Manchester, United Kingdom

  • School of Medicine, Cardiff University, Cardiff, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Newcastle Haemophilia Comprehensive Care Centre, Royal Victoria Infirmary, Newcastle upon Tyne, England, United Kingdom

  • Oxford University Hospitals NHS Trust Biomedical Research Centre, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • NN7008

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved